COCRYSTAL PHARMA, INC. Increase (Decrease) in Deferred Charges
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Deferred Charges of $3.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2020-11-13
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for the quarter ending 2019-03-31 was $3.00K, a 50.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for the quarter ending 2018-12-31 was $7.00K, a 61.11% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for fiscal 2018 was $28.00K, a 12.50% decline from fiscal 2017.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for fiscal 2017 was $32.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred charges for fiscal 2016 was -$2.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 6 month as first filed | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $3.00K 10-Q · filed 2020-11-13 | $10.00K derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.00K 10-Q · filed 2020-08-06 | $10.00K derived: sum of 3 quarters · filed 2020-08-06 | $17.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-13 | $10.00K derived: sum of 2 quarters · filed 2020-05-13 | $17.00K derived: sum of 3 quarters · filed 2020-05-13 | $25.00K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $14.00K derived: sum of 2 quarters · filed 2020-03-27 | $22.00K derived: sum of 3 quarters · filed 2020-03-27 | $28.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $15.00K derived: sum of 2 quarters · filed 2019-11-12 | $21.00K 10-Q · filed 2019-11-12 | $39.00K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $14.00K 10-Q · filed 2019-08-09 | $32.00K derived: sum of 3 quarters · filed 2019-08-09 | $37.00K derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-10 | $24.00K derived: sum of 2 quarters · filed 2019-05-10 | $29.00K derived: sum of 3 quarters · filed 2019-05-10 | $22.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $23.00K derived: sum of 2 quarters · filed 2019-04-01 | $16.00K derived: sum of 3 quarters · filed 2019-04-01 | $32.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$2.00K derived: sum of 2 quarters · filed 2018-08-09 | $14.00K 10-Q · filed 2017-11-08 | $5.00K derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $9.00K 10-Q · filed 2018-08-09 | -$9.00K 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-08-09 | $11.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $16.00K 10-Q · filed 2018-05-10 | $7.00K derived: sum of 2 quarters · filed 2018-05-10 | $18.00K derived: sum of 3 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $2.00K derived: sum of 2 quarters · filed 2018-03-21 | -$2.00K 10-K · filed 2018-03-21 | ||
| 2016-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $7.00K 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | -$4.00K 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |